IP Library Granted Patent US 7,909,809
Granted Patent B2
US 7,909,809 · App. 11/231,293 · Granted Mar 22, 2011

Devices and methods for agent-assisted medical procedures

Assignee: Boston Scientific Scimed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,909,809
App. No.
11/231,293
Granted
Mar 22, 2011
Kind
B2
Abstract

Various embodiments of bulking or cushioning agents or material and related medical devices and methods are disclosed. For example, a method of performing a medical procedure in a tract of a body may include injecting a material in a liquid phase proximate a target site between a first tissue layer and a second tissue layer, allowing the material to transition from the liquid phase to the gel phase in response to a raise in temperature of the material to approximately at or above the predetermined temperature, and performing a surgical procedure on the target site. The material may have the liquid phase at temperatures below a predetermined temperature and a gel phase at temperatures approximately at or above the predetermined temperature.

Claims (51)

1. A method of performing a medical procedure in a tract of a body, comprising:

injecting a material in a liquid phase proximate a target site between a first tissue layer and a second tissue layer, the material having the liquid phase at temperatures below a predetermined temperature and having a gel phase at temperatures approximately at or above the predetermined temperature, wherein injecting the material causes a surface of the first tissue layer to protrude into the tract;

wherein after the injecting step, the material transitions from the liquid phase to the gel phase in response to a raise in temperature of the material to approximately at or above the predetermined temperature so that the surface of the first tissue layer remains protruded into the tract; and

performing a surgical procedure on the target site.

2. The method of claim 1 , further comprising removing the material from the target site, wherein the surface of the first tissue layer returns to a non-protruded state when the material is removed from the target site.

3. The method of claim 1 , wherein performing a surgical procedure comprises removing tissue from the target site.

4. The method of claim 1 , further comprising positioning an endoscope in the vicinity of a target site.

5. The method of claim 1 , wherein the predetermined temperature is a temperature of the body.

6. The method of claim 1 , wherein the material comprises polyoxyethylene-polyoxyproplyene block copolymers.

7. The method of claim 6 , wherein the molecular weights of the block copolymers ranges from approximately 5,000 to approximately 25,000.

8. The method of claim 1 , wherein the material remains in the gel phase for at least approximately 30 minutes.

9. The method of claim 1 , wherein the first tissue layer is a mucosal tissue layer and the second tissue layer is a submucosal tissue layer.

10. The method of claim 1 , wherein the tract is a gastrointestinal tract.

11. The method of claim 1 , wherein the material comprises poly(n-isopropyl acrylamide).

12. The method of claim 1 , wherein the material comprises thermally sensitive inorganic-organic hybrid gels.

13. The method of claim 1 , wherein the material comprises thermally sensitive block copolymer.

14. The method of claim 13 , wherein the thermally sensitive block copolymer comprises poly(N-isopropyl acrylamide-b-dl-lactide).

15. The method of claim 1 , wherein the material comprises polyvinyl alcohol.

16. The method of claim 1 , wherein the material is configured to be responsive to a change in pH level.

17. A method of performing a medical procedure in a tract of a body, comprising:

injecting a material in a liquid phase proximate a target site between a first tissue layer and a second tissue layer, the material having the liquid phase at temperatures below a predetermined temperature and having a gel phase at temperatures approximately at or above the predetermined temperature;

wherein after the injecting step, the material transitions from the liquid phase to the gel phase in response to a raise in temperature of the material to approximately at or above the predetermined temperature;

performing a surgical procedure on the target site; and

removing the material from the target site, wherein removing the material comprises injecting a cold fluid into the target site in contact with the material, allowing the material to transition from the gel phase to the liquid phase.

18. A method of performing a medical procedure in a tract of a body, comprising:

injecting a material in a liquid phase proximate a target site between a first tissue layer and a second tissue layer, the material having the liquid phase at pH levels below a predetermined pH level and having a gel phase at pH levels approximately at or above the predetermined pH level, wherein injecting the material causes a surface of the first tissue layer to protrude into the tract;

wherein after the injecting step, the material transitions from the liquid phase to the gel phase in response to a raise in pH of the material to approximately at or above the predetermined pH level so that the surface of the first tissue layer remains protruded into the tract; and

performing a surgical procedure on the target site.

19. A method of performing a medical procedure in a tract of a body, comprising:

injecting a material in a liquid phase proximate a target site between a first tissue layer and a second tissue layer, the material having the liquid phase at temperatures below a predetermined temperature and having a gel phase at temperatures approximately at or above the predetermined temperature;

wherein after the injecting step, the material transitions from the liquid phase to the gel phase in response to a raise in temperature of the material to approximately at or above the predetermined temperature;

performing a surgical procedure on the target site; and

removing the material from the target site, wherein removing the material comprises injecting a fluid into the target site in contact with the material, wherein the fluid has a temperature sufficiently low to cause the liquid to transition from the gel phase to the liquid phase.

20. A method of performing a medical procedure in a tract of a body, comprising:

injecting a material in a liquid phase proximate a target site between a first tissue layer and a second tissue layer, the material having the liquid phase at temperatures below a predetermined temperature and having a gel phase at temperatures approximately at or above the predetermined temperature, wherein injecting the material causes a surface of the first tissue layer to protrude into the tract;

wherein after the injecting step, the material transitions from the liquid phase to the gel phase in response to a raise in temperature of the material to approximately at or above the predetermined temperature so that the surface of the first tissue layer remains protruded into the tract; and

resecting tissue from the target site.

21. The method of claim 20 , further comprising positioning an endoscope in the vicinity of the target site.

22. The method of claim 20 , wherein the predetermined temperature is a temperature of the body.

23. The method of claim 20 , wherein the tissue that is resected is diseased tissue.

24. The method of claim 20 , wherein the resecting is performed with a resecting device delivered through a lumen of an endoscope.

25. The method of claim 20 , wherein the material remains in the gel phase for at least approximately 30 minutes.

26. The method of claim 20 , wherein the first tissue layer is a mucosal tissue layer and the second tissue layer is a submucosal tissue layer.

27. The method of claim 20 , wherein the tract is a gastrointestinal tract.

28. The method of claim 20 , wherein the resecting is performed with at least one of scissors, biopsy forceps, or a snare.

29. The method of claim 20 , wherein the material is configured to be responsive to a change in pH level.

30. The method of claim 20 , wherein injecting the material is performed with an injection needle.

31. The method of claim 30 , wherein the injection needle is delivered via a lumen of an endoscope.

32. The method of claim 20 , further comprising removing the material from the target site.

33. The method of claim 32 , wherein removing the material comprises injecting a fluid into the target site in contact with the material, wherein the fluid has a temperature sufficiently low to cause the liquid to transition from the gel phase to the liquid phase.

34. The method of claim 20 , further comprising removing the material from the target site, wherein the surface of the first tissue layer returns to a non protruded state when the material is removed from the target site.

Assignments (1)
MERGER Recorded Apr 16, 2012
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 028049/0326 →
Continuity (2)
Provisional Application 60612797 · Sep 27, 2004
Related Publication 20060070631A1 · Apr 6, 2006